IL17A and Alzheimer disease: Although the acute phase of AD is traditionally thought to be strongly influenced by Th2 and Th22 lymphocytes, recent investigations have highlighted the significant impact of Th17 lymphocytes, IL-17, and IL-23 on modulating the pathology of the acute phase of AD.